Iguratimod: all 22 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITPNot yet recruitingNCT07057778Phase 2
- Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHDRecruitingNCT06244628Phase 1/2
- Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid ArthritisRecruitingNCT06146972Phase 4
- Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementRecruitingNCT05789030Not applicable
- The Clinical Efficacy of Immunomodulators in RA PatientsRecruitingNCT05626348Phase 4
- The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's SyndromeRecruitingNCT04981145Phase 4
- A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateCompletedNCT00965757Phase 3Results posted
- Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05302024Phase 2
- The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05281068Phase 2
- Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)Status unknownNCT05216757Phase 2/3
- The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RACompletedNCT04928066Phase 4
- A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.Status unknownNCT04830644Phase 2
- Iguratimod in Systemic SclerosisStatus unknownNCT04515706Not applicable
- The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months TreatmentCompletedNCT03855007Phase 4
- Iguratimod as Treatment for Refractory Lupus NephritisStatus unknownNCT03054545Not applicable
- Study of Iguratimod in Sjögren's SyndromeStatus unknownNCT03023592Phase 1/2
- The Iguratimod Effect on Lupus Nephritis (IGeLU)Status unknownNCT02936375Phase 2
- Iguratimod in Kidney Transplant RecipientsStatus unknownNCT02839941Not applicable
- Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid ArthritisStatus unknownNCT02275299Phase 4
- Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRIStatus unknownNCT01893151Phase 4
- A Study of Iguratimod in Patients With Active Rheumatoid ArthritisCompletedNCT01554917Phase 4
- Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid ArthritisStatus unknownNCT01548001Phase 4